Loading
Alphavirus Infections · Journal article
Virulence · June 18, 2026
Early or partial results. Treat as a signal, not a conclusion.
This reverse genetics study demonstrates that the Getah virus 3'UTR is plastic and tolerates large deletions while remaining viable, with a comprehensive 310-nucleotide deletion mutant showing significant attenuation in murine models and impaired vector competence in mosquitoes. The work identifies the 3'UTR as a regulator of viral fitness and pathogenesis through modulation of host interferon and MAPK signaling, supporting rationale for live-attenuated vaccine development, but remains at the preclinical stage without clinical efficacy or safety data.
Reverse genetics with targeted deletions in cell culture and murine infection models. Laboratory-reared mice (neonatal and weaned age groups); Culex mosquitoes; cultured cell lines (specific types not specified in excerpt provided).. Intervention: Comprehensive 3'UTR deletion mutant (rGETV-KO310) and additional targeted deletions of conserved repeat sequence elements (RSEs).. Compared with: Wild-type or parental GETV strains (exact comparator specification not fully detailed in excerpt)..
GETV 3'UTR tolerates consecutive deletion of up to 310 nucleotides while remaining viable. Comprehensive deletion mutant (rGETV-KO310) exhibited profoundly attenuated virulence, eliciting only transient morbidity with no mortality in both neonatal and weaned mice. rGETV-KO310 displayed significant defect in early colonization within mosquito vectors, indicating impaired vector competence.
Comprehensive deletion mutant (rGETV-KO310) exhibited profoundly attenuated virulence, eliciting only transient morbidity with no mortality in both neonatal and weaned mice.
This preclinical work provides mechanistic rationale for vaccine development via 3'UTR attenuation but does not establish clinical safety or efficacy. Practitioners should await vaccine candidate evaluation in relevant animal disease models and controlled trials before clinical application.
Reverse genetics study in cell culture and animal models establishing the GETV 3'UTR's role in replication and pathogenesis, but lacks clinical translation, human data, and comparative efficacy evidence needed for practice-changing or strong designation.
As stated by the source record.
Quoted from the source exactly as published.
This preclinical work provides mechanistic rationale for vaccine development via 3'UTR attenuation but does not establish clinical safety or efficacy. Practitioners should await vaccine candidate evaluation in relevant animal disease models and controlled trials before clinical application.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Getah virus (GETV), a mosquito-borne arbovirus of the Alphavirus genus, poses an emerging threat to livestock economies and public health, underscored by its expanding host range and association with recent outbreaks of heightened virulence. While the functional significance of the 3' untranslated region (3'UTR) in alphavirus biology is recognized, its specific role in GETV remained undefined. Herein, we elucidate the virological functions of the GETV 3'UTR through a reverse genetics approach, generating a panel of viruses with targeted deletions. We demonstrate that the GETV 3'UTR is remarkably plastic, tolerating a consecutive deletion of up to 310 nucleotides while remaining viable. Deletion of conserved repeat sequence elements (RSEs) induced a cell-type-specific replication deficiency in vitro and significantly attenuated virulence in a murine model. A comprehensive deletion mutant (rGETV-KO310) exhibited further impaired replication kinetics in vitro and was profoundly attenuated in vivo, eliciting only transient morbidity with no mortality in both neonatal and weaned mice. Furthermore, this mutant displayed a significant defect in early colonization within mosquito vectors, indicating a role in vector competence. Comparative transcriptomic profiling of knee joints revealed that attenuation correlates with the altered modulation of critical host immune responses, notably the interferon and MAPK signaling pathways. Collectively, these findings establish the GETV 3'UTR as a pivotal regulator of viral fitness, pathogenesis, and transmission. This work provides a foundational rationale for the strategic development of live-attenuated vaccine candidates based on targeted 3'UTR attenuation.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.